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ABSTRACT
Quinolonesareantibacterialdrugsthatarethoughtto
bind preferentially to disturbed regions of DNA. They
do not fall into the classical categories of intercalat-
ors, groove binders or electrostatic binders to the
backbone. We solved the 3D structure of the DNA
duplex (ACGCGU-NA)2, where NA denotes a nalidixic
acid residue covalently linked to the 20-position of
20-amino-20-deoxyuridine, by NMR and restrained tor-
sion angle molecular dynamics (MD). In the complex,
the quinolones stack on G:C base pairs of the core
tetramer and disrupt the terminal A:U base pair. The
displaced dA residues can stack on the quinolones,
while the uracil rings bind in the minor groove.
The duplex-bridging interactions of the drugs and
the contacts of the displaced nucleotides explain the
high UV-melting temperature for d(ACGCGU-NA)2 of
up to 53 C. Further, non-covalently linked complexes
between quinolones and DNA of the sequence
ACGCGT can be generated via MD using constraints
obtained for d(ACGCGU-NA)2. This is demonstrated
for unconjugated nalidixic acid and its 6-fluoro deriv-
ative. The well-ordered and tightly packed structures
thus obtained are compatible with a published model
for the quinolone–DNA complex in the active site of
gyrases.
INTRODUCTION
Quinolones are heterocycles with a bicyclic core structure (1,
Figure 1). They are known for their ability to inhibit bacterial
topoisomerases (1). Quinolones have been used clinically for
over 40 years, and some drugs from this class of compounds,
such as levoﬂoxacin and ciproﬂoxacin, are not only among
the most frequently prescribed anti-infectives worldwide but
also constitute the drug of choice against some life-threatening
infections, including those by anthrax. Even mycobacterial
infections can be treated with ﬂuoroquinolones (2). Most clin-
ically relevant quinolones contain a carboxylicacid function at
position 3 and bulky substituents at one face of the bicyclic
core, namely at positions 1 and 7 and/or 8, as shown schem-
atically in structure 2. Their aromatic core is smaller than that
oftypical intercalators, and their substituentsare bulky enough
to appear as protuberances from the plane of the aromatic ring,
making it unlikely that they are part of an intercalated entity.
Though it is known that quinolones are active against topo-
isomerases of type II (gyrases) and type IV (3), the molecular
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Figure 1. Structures of quinolones.
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doi:10.1093/nar/gki795details of their mode of action remain unclear. Gyrases cleave
both strands of bacterial DNA, pass a double strand through
the opening and re-ligate the cut ends to produce supercoils
(4). The quinolones do not prevent the cleavage of the DNA
but they interfere with the strand passage and re-ligation by
stabilizing an intermediate of the catalytic cycle (5). If the
enzyme falls off before the re-ligation of the DNA, double-
strand breaks are introduced (6). Alternatively, the stabiliza-
tion of an intermediate can arrest transcription or replication.
X-ray structures of gyrase subunits exist and detailed mech-
anisms forgyraseinhibitionhave been proposed(7–13),butno
structure of a complex with substrate double-stranded DNA
(dsDNA) and/or quinolones has been solved. Also, no high-
resolution structures of quinolones non-covalently bound to
DNA are available, though detailed physicochemical studies
have shown afﬁnity for dsDNA and single-stranded DNA
(ssDNA) (14–16). It was concluded that quinolones bind to
dsDNA in a mode that does not seem to be classical intercala-
tion, classical groove binding or surface binding, but that the
plane of the quinolone is near-perpendicular to the helical axis
of the DNA (17). The distortion of the DNA induced by the
gyrase is believed to favor binding of the drug to the nucleic
acid. One model proposes cooperative binding of four quino-
lones to a bubble in dsDNA (18), whereas another proposes
that two quinolones bind apart from each other and displace
one nucleobase each in the DNA (19). In the ternary complex
of quinolones, DNA and gyrase, ﬁxation of the quinolones in
space by chelation of the carboxyl group and the carbonyl
group to a Mg
2+ ion that also coordinates to the DNA has
been proposed previously (20). The two most popular models
are qualitative, and precise coordinates for all components
have not been generated.
Given the present inability to obtain high-resolution
DNA–quinolone structures without the preorganizing effect
of the gyrase (which in turn resists crystallization as a
substrate–enzyme complex), preorganizing DNA and quino-
lones through covalent bonds that favor binding even for
undisturbed DNA by ensuring a high local concentration of
the ligand is perhaps worthwhile. There is evidence that tight
and well-deﬁned complexes can form in covalently linked
hybrids. Nuclease selection assays employing synthetic librar-
ies of acylated DNA strands revealed oxolinic acid (3) and
cinoxacin (4) as duplex-stabilizing 50-substituents (21–23). In
addition, assays involving dynamic combinatorial libraries
have identiﬁed nalidixic acid residues as substituents that sta-
bilize duplexes with RNA targets (24,25). Nalidixic acid resi-
dues linked to ssDNA also enhance nuclease stability (26).
Finally, the same residue stabilizes duplexes when linked to
the 20-position of a 20-amino-20-deoxyuridine residue at the
30-terminal position of oligodeoxynucleotides (27).
For most covalently linked DNA–quinolone constructs, the
details of the interaction between the nucleic acid and the drug
have not yet been elucidated. One modeled structure for a
complex involving two quinobenzoxaxines and two quino-
lones bound to DNA via complexation of four magnesium
ions has been published previously (28), but the quinolones
are extrahelical and have few contacts with the DNA. Also, a
high-resolution structure has been obtained for a DNA duplex
with 50-appended oxolinic acid residues (29). The structure of
the oxolinic acid–DNA complex with its disrupted T:A
base pair is reminiscent of the model for non-covalent
quinolone–DNA complexes proposed by Heddle et al. (30).
The covalent link in this complex has led others to speculate
(incorrectly) that a covalent link was also implied for the
complex of quinolone, DNA and gyrases in vivo (31). Perhaps
more importantly, attempts to model non-covalent quinolone–
DNA complexes after this structure have been unsuccessful.
This prompted us to continue the search for stable and well-
deﬁned quinolone–DNA complexes, hoping to identify a more
suitable one for modeling non-covalent complexes that are
consistent with the structure–activity information available
for quinolones. A covalently linked quinolone–DNA hybrid
was recently identiﬁed that gives a melting temperature (Tm)
muchhigherthanthatofthe unmodiﬁedcontrolduplex.Thisis
the duplex d(ACGCGU-NA)2 (6)2 (Figure 2) (27). Its UV-
melting temperature is up to 22 C higher than that of
d(ACGCGT)2. The hybrid has the quinolone attached to the
20-position of a 30-terminal residue. Here we present a high
resolution structure of (6)2, together with biophysical data
on other quinolone–DNA constructs and two modeled non-
covalent quinolone complexes, based on structural constraints
for (6)2.
MATERIALS AND METHODS
Synthesis
A sample of ACGCGU-NA (6) for NMR spectroscopy
was synthesized following a route reported earlier (27) on a
6 mmol scale, using a Perseptive Biosystems 8909 Expedite
DNA synthesizer, starting from controlled pore glass loaded
with the quinolone-bearing nucleoside (27). Octamer
d(CGGTTGAU-NA) (7) was prepared analogously, except
that DNA synthesis of the unmodiﬁed portion was performed
on a 1 mmol scale on an ABI 380 DNA synthesizer, following
the manufacturer’s recommendations. Nalidixic acid was
obtained from Aldrich (Taufkirchen, Germany). The phos-
phoramidites used for the DNA syntheses were obtained
from Proligo (Hamburg, Germany). MALDI-TOF spectra
were recorded on Bruker BIFLEX III or REFLEX IV spec-
trometers in negative, linear mode, using a matrix mixture of
2,4,6-trihydroxyacetophenone (0.3 M in ethanol) and diam-
monium citrate (0.1 M in water) (2:1, v/v). Oligonucleotides
were puriﬁed by high-performance liquid chromatography
(HPLC) on a Macherey-Nagel Nucleosil C4 column
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Figure 2. Structure of the duplex of compound 6.
Nucleic Acids Research, 2005, Vol. 33, No. 15 4839(250 mm · 4.6 mm), using a gradient of CH3CN (solvent B)
in 0.1 M triethylammonium acetate, pH 7, and detection
at 260 nm.
d(ACGCGU-NA) (6)
Yield: 11%, as determined based on cpg loading; HPLC gra-
dient: 0% B for 5 min to 25% B in 40 min, Rt ¼ 42 min;
MALDI-TOF MS m/z for C63H84N35O36P5 [M–H]
 : calcd
2007.8, found 2006.0.
d(CGGTTGAU-NA) (7)
Yield: 85%, as determined based on the HPLC integration
of the crude; HPLC gradient: 0% B for 10 min to 30% B
in 30 min, Rt ¼ 29.4 min; MALDI-TOF MS m/z for
C90H110N32O50P7 [M–H]
 : calcd 2656.9, found 2655.7.
UV-melting experiments
UV-melting experiments were performed as reported pre-
viously (29). The extinction coefﬁcients of the hybrids were
calculated as the sum of the extinction coefﬁcients of the DNA
portion and an e260 for nalidixic acid of 22000 M
 1 cm
 1. Tms
are the extrema of the ﬁrst derivatives of the 91-point
smoothed curves, and hyperchromicities are DE260 between
high and low temperature baselines, and divided by the E260
at low temperature.
Sample preparation and NMR spectroscopy
The modiﬁed DNA was lyophilized three times from
10% aqueous NH3 and twice from D2O. A sample of 6
(0.65 mmol) was taken up in phosphate-buffered saline buffer
(200 ml; containing NaCl, KCl, Na2HPO4 and KH2PO4) made
up in 99.9% D2O to pH 7 (uncorrected for deuterium effect)
and transferred to a susceptibility-matched NMR tube
(Shigemi Co., Tokyo, Japan). For spectra containing signals
of exchangeable protons, the solution was dried and the re-
siduetakenupinH2O/D2O(9:1,230ml).Spectraforgenerating
constraints were acquired on a Bruker Avance 800 spectro-
meter at Bruker Biospin (Rheinstetten, Germany) at 283 K
and spectral widths of 8741 (D2O samples) and 15 432 Hz
(H2O/D2O, 9:1 samples). Suppression of the excess solvent
peak was achieved by presaturation during the recycle delay
(D2O samples) or the WATERGATE gradient pulse sequence
(32) (H2O/D2O samples). Relaxation times were assumed to
be similar to those reported for other modiﬁed DNA hexamer
duplexes (33). The repetition delay was set to 2 s, a value
larger than the T1 times estimated from inversion-recovery
experiments. Data acquired included NOESY spectra at mix-
ing times of 62.5, 150 and 250 ms, DQF-COSY, TOCSY and
HSQC spectra. Spectra were recorded with 256, 512 or 1024
increments in F1 and 8000 in F2, 16 or 32 scans per increment
and were processed using XWINNMR (Bruker Instruments)
and Sparky (version 3, available from Drs T. D. Goddard and
D. G. Kneller, UCSF).
Resonance assignments
The resonances of the methyl and ethyl groups of the nalidixic
acid residue were identiﬁed in the 1D spectrum, and the
assignments were conﬁrmed in NOESY, COSY and TOCSY
spectra. The aromatic protons of the nalidixic acid were iden-
tiﬁed based on NOESY crosspeaks to the methyl and ethyl
groups. Sequential assignment of H10 and H6/8 protons of the
nucleotides of the pentamer d(CGCGU) followed an estab-
lished protocol for duplex DNA (34–36). Starting from H10
signals of each nucleotide, the spin systems of the deoxyri-
boses were assigned via TOCSY and COSY crosspeaks. The
resonances of H20 and H200 were stereospeciﬁcally assigned
basedontheintensityofcrosspeakstoH10,H3 0 andH50/H500in
the NOESY spectrum at 62.5 ms mixing time (H10 is closer to
H200,H 3 0 and H50 were assumed to be closer to H20). Further,
their COSY crosspeaks to H30 were inspected. All H20 reson-
ances were found to be upﬁeld of H200, as expected for B-form
DNA (37). The resonances H50/H500 were stereospeciﬁcally
assigned, if possible, based on the scalar coupling to H40 (38)
and the assignment was conﬁrmed based on the distances to
neighboring protons in reﬁned structures. The resonance of H2
of A1 was the only unassigned singlet left in the aromatic
region, which also led to the deoxyribose spin system of
A1 via the H2–H10 crosspeak. Resonance H6 of U6 led to
the ribose spin system via a NOESY crosspeak. The exchange-
able protons were assigned starting from the resonances of H1
of the dG residues in the low-ﬁeld region of the spectra
acquired in H2O/D2O. The strongest NOESY crosspeak to
H1 was assigned to H42 of the pairing dC residue, which
led to H41. Strong crosspeaks from H41 to H5 of the respect-
ive dC residue provided the assignment to a speciﬁc base pair.
The amidic NH at position 20 of the dU residue was identiﬁed
based on NOESY crosspeaks to neighboring H10 and H20
resonances. Of residue A1, only one resonance was found
for the amino group at position 6, which was assigned by
the crosspeak to A1H2 and by the peaks to the nalidixic
acid moiety after the general structure of the duplex was
known. The protons H21 and H22 of the dG residues and
H3 of uridine were not observed, probably due to rapid
exchange with solvent.
Constraints
Crosspeaks in a NOESY spectrum of a D2O solution of 6 with
a mixing time of 250 ms were integrated using Sparky, pro-
ducing intensities thatwereused tocalculate initial interproton
distances via the isolated spin system approximation. Known
distances, such as those between vicinal aromatic protons in
cytosine, uracil and nalidixic acid or those between geminal
protons of methylene groups, were used for calibration.
Besides ﬁxing a general value for spectral noise, each peak
was assigned its own error percentage. The errors used were
10% for all well-resolved peaks, integrated by ﬁtting a
Gaussian peak shape, and 20% for peaks within 0.33 ppm
of the diagonal. Some of the errors thus determined automat-
ically were adjusted manually after judging the peak and its
surrounding background. After the general structure of the
complex had been established, based on over 60 unambiguous
NOE-derived distance constraints, a signiﬁcant contribution of
interstrand NOEs between protons of the deoxyriboses of the
core tetramer could be excluded. The initial structures were
used to compute reﬁned distance constraints in MARDIGRAS
(39) from integration values of NOESY crosspeaks via relaxa-
tion matrix calculations. The RANDMARDI version of the
software was used to account for integration error and spectral
noise (40) (>10 model structures, 500 samples, in 4–50 iter-
ative steps each). Calculations were run with 3.5 and 4.5 ns
4840 Nucleic Acids Research, 2005, Vol. 33, No. 15correlation time, assuming isotropic tumbling, for NOESY
spectra at three mixing times (62.5, 150 and 250 ms). The
results from all six calculations were averaged using the
‘avgmar’ routine of MARDIGRAS. The values of ‘low1’
and ‘up2’ of the averaging step were used as upper and
lower boundsof the constraints, yielding constraint boundaries
ranging from ±0.2 to ±2 s, with an average value of ±1 s.
Hydrogen bonding constraints were entered for the Watson–
Crick base pairs of the (CGCG)2 core, and between NH6 of A1
and O30 of U6. Omitting the latter does not affect the fold of
(6)2. Further, very weak NCS constraints (weight ¼ 3,
B-value ¼ 15) were used for the calculation of the ﬁnal struc-
tures, to facilitate the generation of more symmetrical dimers.
Constraints based on trivial crosspeaks, solely deﬁning the
primary structure, were not entered. The resonances of the
H10 protons of the residues of the core tetramer appear as
tripletswith thesumofthe couplingconstants>12Hz.Further,
H200–H30 andH30–H40 crosspeakpatternsinDQF-COSYspec-
tra are consistent with B-form DNA. Therefore, a B-type
dihedral angle constraint for backbone angle g of C4 was
entered with boundaries of ±30 . Restraining all backbone
angles of the core tetramer with values typical for B-form
DNA analogously to calculations reported for other DNA
hexamers (29,41) did not alter the fold of (6)2. During reﬁne-
ment, separate calculations were performed for the two stack-
ing modes of dangling residue A1. For one set of these, six
additional NOE-based constraints were entered for A1 in syn
conformation. For calculations focused on A1 in anti con-
formation, two other NOE-based constraints and one repulsive
constraint were entered. Omitting the repulsive constraint dur-
ing restrained molecular dynamics (MD) gave occasional
structures where A1 was in the minor groove, a location for
this residue in clear violation of the existing NOE information,
thus lowering the yield of accepted structures, but does not
change the fold of (6)2. The constraints used for either focused
set of calculations are given in Supplementary Table S3.
Omitting these constraints yields structures with the same
fold as that seen in the focused calculations, except for a
poorly deﬁned localization of A1.
Structure generation
Generation of topology ﬁles and coordinates for extended
strands, as well as restrained MD calculations themselves,
were carried out in CNS (42), version 1.1, on LINUX plat-
forms, compiled with Intel ifc compiler, version 6.0. For the
unmodiﬁed part of the DNA, parameters supplied with CNS
were used. For the 20-amino modiﬁed uridine, the CNS para-
meters for uridine were used, with a patch exchanging the 20
oxygen to an NH group. Structural parameters for the nalidixic
acid residue were calculated at the level HF/4-21G** in Gaus-
sian 94, converted to CNS format with Xplo2D 3.2.1 (43), and
carefully edited to remove unnecessary improper, dihedral and
angle constraints. Restrained MD calculations were performed
in CNS, using the torsion angle MD option (44) with setting
identical tothose employedinearlierwork (41).See Table 5in
Ref. (45) for a compilation of the computational steps. The
methyl group M9 and the ethyl group of the cap were excluded
from this NCS potential. For reﬁnement, restraint violations
and restraint distribution over the structure were visualized
using VMD (46) and a plug-in for visualizing the entered
constraints and error bounds written in-house. Back-calculated
NOESY spectra were generated with CORMA from the MAR-
DIGRAS package, using the full relaxation matrix, and dis-
played in Sparky. Table 1 comprises data on constraints used,
and Supplementary Figures S1 and S12 show constraints
deﬁning the position of N7 and the central G3C4 dinucleotide
in graphical form.
RESULTS
The 1D NMR spectrum of duplex (6)2 shows one predominant
set of signals and some truly minor signals (<5% intensity)
that are too small to allow for assignment (Figure 3). Although
the material used was puriﬁed by HPLC and MALDI-TOF MS
(see Supplementary Material), we cannot rigorously exclude
that these signals are caused by residual failures from the
synthesis. It is also possible that (6)2 can adopt an additional
state of much lower stability, in which the quinolone is not
intercalated. Given the very low intensity of these additional
signals, no attempts were made to pursue them further. For the
dominatingset ofsignals, sequential assignmentofthe H10 and
H6/8 resonances (34–36) was possible for the core tetramer
Table 1. Constraints
a used for MD calculations on (6)2 and results
Conformation I
b Conformation II
b
NOE-based constraints (total) 252 246
Interresidue 172 170
Intraresidue 80 76
Dihedral angle constraints 2
c 2
c
Hydrogen bonding constraints 12/14
d 12/14
d
Base pair planarity constraints 8 8
Violations: no violations of distance and dihedral constraints
Statistics for the 10 lowest energy structures
r.m.s.d. (s) from average (all atoms) 0.60 0.71
(backbone) 0.71 0.75
aGivenisthetotalnumberofconstraintsenteredforcalculationsinvolvingboth
strands of the symmetrical dimer.
bConstraints for conformations I (A1 adopts syn conformation) and II (A1
adopts anti conformation) differ only in constraints to and within A1. See
Supplementary Table S3 for a listing.
cOnly the dihedral angle g of C4 was constrained.
dForthecoretetramer,12H-bondconstraintsforbasepairswereused,looseH-
bond constraints between NH6 of A1 and O30 of U6 were entered but proved
inconsequential for the structures obtained.
Figure 3. Lowfieldregionofthe
1H-NMRspectrumofd(ACGCGU-NA)2(6)2
in buffered D2O at 800 MHz and 283 K.
Nucleic Acids Research, 2005, Vol. 33, No. 15 4841d(CGCG)2, and the nalidixic acid residue gave NOEs to both
C2 and U6 (Figure 4), suggesting that the terminal portion of
the duplex featured an intercalated quinolone. In the spectrum
acquired from a solution of H2O/D2O, peaks for the imino
protons of the C:G base pairs were observed in the typical
chemical shift range >12 ppm A comparison with the
unmodiﬁed control duplex (ACGCGU)2 shows signiﬁcant
chemical shift differences of >0.2 ppm for either H10 and/or
nucleobase resonances of residues A1, C2, G5 and U6 (Sup-
plementary Figures S9 and S10). Restrained torsion angle MD
(44) with distance constraints based on integration of NOESY
crosspeaks gave a ﬁrst set of structures with the quinolone
rings displacing the terminal U:A base pairs. The structure was
subjected to reﬁnement based on a relaxation matrix treatment
of the NOESY crosspeak intensities. Overall, >300 MD cal-
culations, each leading to at least 80 individual structures,
were performed to reﬁne the structure.
Conﬂicting constraints involving residue A1 initially com-
plicated the reﬁnement. For example, H2 of this residue’s
nucleobase shows NOEs to neighboring protons located in
the major groove and to neighboring protons pointing toward
the minorgroove.Thissuggeststhatthedanglingresidue isnot
ﬁxed and adopts more than one conformation on the NMR
time scale. This is consistent with the sligthly reduced line
widths observed for H2 and H8 of A1, which indicate
increased mobility. The half height peak widths for these
resonances at 10 C are 4.7 and 4.9 Hz, whereas those of
H8 of G3 and G5 are 5.3 and 5.8 Hz. A set of
1H-NMR spectra
acquired at 5 C temperature intervals shows that resonances of
A1, such as H10, broaden only moderately when the duplex
begins to melt at 45 C, and re-sharpen at 60 C, a temperature
where resonances of the core duplex are still broad. This
conﬁrms that the 30-terminal residue does engage in detectable
interactions with the duplex but becomes fully disordered at a
lower temperature than the nucleotides forming Watson–Crick
base pairs.
Rather than letting this residue rotate freely in calculations,
attempts were made to identify states in which A1 comes
within stacking distance to the neighboring residues, resulting
in the NOESY crosspeaks observed. Two conformations that
show stacking of A1, albeit in different arrangements relative
to the remainder of the structure, and with either a syn or an
anti conformation for A1 itself, were thus generated. Together,
they fully explain the NOEs observed in the NOESY spectra.
The crosspeak between H8 and H10 of A1 is between 4.5 and
6 times more intense than those of the other purines in the
NOESY spectra acquired, as expected for a residue adopting a
syn conformation. An overlay of a total of 20 lowest energy
structures, 10 each from either conformation, is shown in
Figure 5. Figure 6 shows an overlay of the experimental
and the back-calculated NOESY spectrum of (6)2, and
Table 1 provides detailed information on the structures. It
is important to emphasize that the remainder of the complex
is unaffected by the dangling motions of A1. This can be seen
from Figure 5 and Supplementary Figure S11 where an
overlay of the back-calculated NOESY spectra from either
conformation is shown.
In either of the two stacked conformations, A1 places about
half of the surface of its purine ring system on the quinolone
moiety (Figure 7). The adenine ring is also close enough to the
ribose ring of U6 to allow for at least transient hydrogen
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Figure 4. Expansion of the NOESY spectrum of (6)2 in buffered D2Oa t
800MHz,283Kand250msmixingtimeshowingNOEconnectivitiesbetween
H10 resonancesoftheribosesystems,protonsofthenucleobasesandresonances
of the nalidixic acid residue.
Figure 5. Overlay of 20 lowest energy structures of (6)2, as obtained by
restrained torsion angle MD. Ten structures each were obtained from calcula-
tionswithconstraintsfavoringstackingofA1insynandanticonformation.The
graphic was generated with VMD (46). See Supplementary Figure S13 for
separate overlays of structures from either conformation.
4842 Nucleic Acids Research, 2005, Vol. 33, No. 15bonding with the 30-hydroxyl group of this nucleotide. In the
spectra of (6)2 in H2O/D2O, a signal is observed above 6 ppm
that was assigned to NH6 of A1. In the syn-like conformation I
of this nucleoside several structures show a H-bonding dis-
tance to O30 of U6. This putative hydrogen bonding interac-
tion, in which NH6 of A1 acts as donor and O2 of U6 as
acceptor is highlighted in Figure 8. In stacking mode II,
where A1 adopts the anti conformation, a similar hydrogen
bond is possible. Figure 8 also shows an additional possible
hydrogen bond between O2 of U6 and NH2 of G5 that can be
inferred from the spatial closeness of donor and acceptor
groups, but could not be detected directly in this solvent-
exposed position. In either stacking mode of A1, the pyrimi-
dine is close enough to the purine’s amino group to allow for
this interaction.
The terminal residues can arrange themselves into a tightly
packed structure in either conformation. The kink in the back-
bone between G5 and U6 places the ribose ring of U6 vertic-
ally above the deoxyribose of G5. The ribose ring thus
complements the quinolone in taking up the space usually
occupied by a base pair. The methyl group at position 7 of
the nalidixic acid residue stacks against the deoxyriboses and
A1 and C2, and the ethyl group at position 1 is located in the
major groove, where it can engage in (transient) hydrophobic
interactions with the neighboring nucleotides. The orientation
of this ethyl group is not well ﬁxed in space, though, as evid-
enced by NOEs to protons from several surrounding residues.
Theglobalshape ofthedisruptedduplexissurprisinglysimilar
to that of an undisturbed Watson–Crick double helix, and the
displaced nucleotides do not lead to a ‘bubble’ in the helix.
The core duplex d(CGCG)2 also shows a largely undisturbed
Watson–Crick geometry.
We next studied whether the base pair-disrupting mode of
binding of the nalidixic acid residue is also found in the pres-
ence of a weak neighboring base pair. The non-self comple-
mentary octamer 7 (Figure 9) was synthesized (27), where the
quinolone-bearing 30-terminal deoxyuridine residue is next
to a dA residue. When subjected to UV-monitored melting
analysis in the presence of the fully matched target strand, 7
gave a 5.5 C higher Tm than that of the unmodiﬁed control
duplex (Table 2). Duplexes with a mismatched nucleobase at
the 50-terminal position of the target did not lead to a signi-
ﬁcant decrease in the Tm, suggesting that U8 does not form
a base pair. At the penultimate position, however,thereis good
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Figure 6. Overlay of experimental (red) and back-calculated (blue) NOESY
spectrumof(6)2(conformationII).Theexperimentalspectrumwasacquiredin
phosphate-buffered D2O at 250 ms mixing time, 283K (red), and the back-
calculated one was generated from the averaged structure of the 10 lowest
energyconformationsinCORMAat250msmixingtimeand3.5nscorrelation
time,importedintoSparky.Crosspeaksoriginatingfromtheunidentifiedminor
resonances (cf. Figure 3) are labeled with crosses. Line widths in the back-
calculated spectrum were increased to facilitate visual inspection. For a com-
parisonoftheback-calculatedspectraofthetwoconformationsthatdifferinthe
stacking mode of A1, see Supplementary Figure S11.
(a)
(b)
Figure 7. Two stacking modes of A1, representing the extremes of the acces-
sible conformational states for the dangling residue. Each portion of the figure
shows two different representations, one a structural drawing of A1, and one a
view from the top along the axis of the helix. (a) Conformation I in which A1
adopts a syn-arrangement, (b) conformation II in which A1 adopts an anti-
arrangement.Eachstackingarrangementwascalculatedusingadifferentsubset
of NOE constraints for A1 and N7 (Supplementary Table S3).
Nucleic Acids Research, 2005, Vol. 33, No. 15 4843base pairing ﬁdelity, with Tm decreases of up to 11.4 C when
mismatches are placed in the target strand. These observations
are in agreement with the notion that the nalidixic acid residue
forcesasimilarstructureontotheterminalregionofthe duplex
of 7 with its target strand as it does in (6)2.
Finally, results from exploratory work with compound
8 (Figure 9), which was prepared in the context of a
combinatorial study, suggests the base pair-disrupting binding
mode of a quinolone (in this case cinoxacin) is also induced
when the nucleobase of the quinolone-bearing residue is aden-
ine rather than uracil. When (8)2 was subjected to degradation
with bovine spleen nuclease, which digests oligonucleotides
from the 50-terminus, its terminal thymidine residue was read-
ily cleaved off, whereas the penultimate nucleotide was
removed more slowly under nuclease attack than that of the
unmodiﬁed control d(TGCGCA)2. This suggests that the ter-
minal residue is sterically accessible, but the penultimate one
is shielded from nuclease attack (Supplementary Figure S7).
This implies that the quinolone again disrupts the terminal
base pair and stacks on the penultimate C:G base pair.
DISCUSSION
Quinolones such as nalidixic acid are too small to act as
classical intercalators. The current structures show one
possible mode of binding to DNA that is open to these
drug molecules, at least when they are covalently attached
to a nucleotide of a weak U/T:A base ‘pair’. The quinolone-
containing terminal region has a global shape reasonably sim-
ilar to that of the remainder of the DNA helix and is well
packed. The drug places itself below one unpaired nucleotide
(A1) and engages the ribose ring of another (U6) in ﬁlling
some of the space vacated by the missing base pair. The
bicyclic quinolone alone is only slightly bigger than a single
purine residue, and would be unable to ﬁll the space of a base
pair by itself. The ‘hemi-intercalation’ places the nucleobase
of U6 in the minor groove of the DNA helix, a site well known
for attracting small molecules. In the structure of (6)2, the
extent to which the ribose ring of the quinolone-bearing res-
idue is pulled over the plane of the last intact base pair is
greater than in the structure of the oxolinic acid-bearing hex-
amer d(OA-TGCGCA)2 (29), but the phenomenon is also
observed in the earlier structure. Unlike the 50-linked oxolinic
acid, the 30-linked nalidixic acid does not force the nucleobase
of the target strand into the minor groove, but that of the
nucleotide to which it is attached.
Duplex-destabilizingeffectsofquinoloneresiduesappended
to residues in the interior of oligonucleotides have also been
observed. The DNA decamer 9 (Figure 9) was recently pre-
pared via solid-phase synthesis and studied in UV-melting
experiments (47). This nalidixic acid-bearing oligonucleotide
gives a Tm with its fully complementary DNA target strand
below 15 C, even at 1 M salt, consistent with the assumption
Figure 8. Terminus of (6)2 with A1 in anti conformation, viewed from the
major groove. Putative hydrogen bonds are shown as blue dotted lines and
the hydrogen bonds in the Watson–Crick base pair as broken blue lines. The
quinoloneisshowningold,theringsystemsofA1andU6arefilledinturquoise,
andthoseoftheC2:G5basepairarefilledinpurple.ThebackbonesoftheDNA
aretracedasyellowribbons,andthenucleotidesoftheremainderoftheduplex
are shown in cartoon style.
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Figure 9. Structures of quinolone-DNA hybrids.
4844 Nucleic Acids Research, 2005, Vol. 33, No. 15thatthequinoloneinterfereswithbase pairingatacentralpoint
oftheduplex.Thisissurprisingasthenalidixicacidislinkedto
position5ofadUresidueviaanalkynyllinkerthatshouldplace
it in the major groove without causing any steric conﬂicts.
The base pair-disrupting binding mode of the nalidixic acid
residue in (6)2 is not a necessary consequence of its site or
mode of covalent attachment. The residue of anthraquinone
carboxylic acid, e.g. a structurally similar aromatic acid,
when linked to the amino group of a 30-terminal 20-amino-
20-deoxyuridine residue of AGGTTGAU, leads to improved
base pairing ﬁdelity at the terminus (23), including good base
pairing ﬁdelity of U8 itself. This suggests that the residue
of this aromatic acid does not disrupt the terminal base
pair. The same is true for some aromatic substituents, such
as pyrene butyric acid, attached to the position 5 of deoxyur-
idine residues in the interior of DNA strands via an alkynyl
spacer. These stabilize DNA duplexes (47) and do not abolish
base pairing selectivity. The same is true for certain other
carboxylic acid residues 50-linked to oligonucleotides (22,48).
To those who wish to develop molecular caps that seal the
termini of duplexes between hybridization probes and target
strands (22,48,49), the structure of (6)2 may seem disappoint-
ing. The quinolone not only fails to cap the terminal base pair,
it favors its disruption. But, the entire acylated nucleotide (U6-
N7) may be treated as one large ‘composite cap’ that can seal
off a terminus. In the structure of (6)2, the residues U6 and N7
together cap the base pair G5:C2. They thus provide a blue-
print for a simpliﬁed cap of the same shape. A simpliﬁed and
easy-to-synthesize cap has been described recently for
50-termini that contains a pyrrolidinol moiety instead of a
ribose residue and a pyrenylmethyl group as stacking unit
(23). Even though this simpliﬁed cap can be synthesized in
two steps from commercially available starting materials, it
markedly increases duplex stability, it improves base pairing
ﬁdelity and it protects against exonuclease attack. To develop
a similar solution in the current case, e.g. in the form of an
aminodeoxyribose nalidixate, is attractive, as known 30-caps
are less satisfactory in terms of their ﬁdelity-increasing effect
than their best 50-attached counterparts (23,48,49). Other
applications of 20-linked quinolone–DNA hybrids may emerge
in the ﬁeld of DNA-based nanostructures (50). If one was to
employthe residue of a different quinolone than nalidixic acid,
which carries a substituent at position 7 of the quinolone
scaffold that can act as a starting point for DNA synthesis,
the resulting ‘branching’ strand can be expected to protrude
from a helix at an angle of  90 , if the quinolone positions
itself like N7 in the structure of (6)2. A T-like structure is a
motive that has achieved a certain prominence in the ﬁeld of
DNA-based nanostructuring, as evidenced by the dsDNA seg-
ments joined by Holliday junctions (51).
Perhaps the most interesting is the possible relevance of
the structure of (6)2 for the biological activity of quinolones.
We are tempted to speculate that the structure observed could
be similar to that formed with DNA in the active site of
gyrases. There are certain arguments that make this reason-
able. Firstly, it seems as if the position of N7 in (6)2 could also
be adopted by other quinolones, including highly active gyrase
inhibitors. All clinically important quinolones possess sub-
stituents at positions 1 and 7 of the heterocyclic ring system.
Positions 1 and 7 are not tightly encased in the structure of (6)2
and bulkier substituents might be accommodated there. Both
the cyclopropyl group at position 1 of drugs such as cipro-
ﬂoxacin and the piperazine moiety found at position 7 of this
and related drugs (e.g. norﬂoxacin or pipemidic acid) should
ﬁnd sufﬁcient space in the major groove of helices with a
structure similar to that of (6)2. Secondly, the structure of
(6)2 also leaves space for purines instead of pyrimidines at
the position currently occupied by U6. The minor groove is
open below the uracil of U6 and should accommodate these
larger nucleobases, as corroborated by the nuclease survival
results for 8 (vide supra). Therefore, other sequence motives
than the one studied here should be able to adopt the
quinolone-induced fold.
Thirdly, the interactions between the quinolone and the
DNA are very strong. At 1 M salt, the UV-melting temperat-
ures for (6)2 and control d(ACGCGT)2 are 53.1 and 31.1 C,
Table 2. UV-melting data for octamer 7 or control strand CGGTTGAT with target strands
Probe
a Target sequence Mismatch Tm ( C)
b [salt] ¼ 150 mM [salt] ¼ 1M DTm to perfect match
at 1 M salt ( C)
c
CGGTTGAT ATCAACCG 30.1 ± 0.5
d 34.3 ± 0.6
d
CGGTTGAU-NA ATCAACCG 34.4 ± 0.7
d 39.8 ± 0.7
d
CGGTTGAT CTCAACCG T:C 23.7 ± 0.8 28.4 ± 0.9  5.9
CGGTTGAU-NA CTCAACCG U:C 33.6 ± 0.9 39.2 ± 0.7  0.6
CGGTTGAT GTCAACCG T:G 25.8 ± 0.6 30.2 ± 0.8  4.1
CGGTTGAU-NA GTCAACCG U:G 34.2 ± 1.0 39.8 ± 0.7 0
CGGTTGAT TTCAACCG T:T 24.4 ± 0.7 29.4 ± 1.0  4.9
CGGTTGAU-NA TTCAACCG U:T 33.4 ± 0.8 39.4 ± 0.7  0.4
CGGTTGAT AACAACCG A:A 21.4 ± 0.2 26.7 ± 0.7  7.6
CGGTTGAU-NA AACAACCG A:A 28.2 ± 1.3 32.8 ± 0.7  7.0
CGGTTGAT ACCAACCG A:C 20.3 ± 0.7 25.1 ± 0.9  9.2
CGGTTGAU-NA ACCAACCG A:C 23.0 ± 1.0 28.5 ± 1.1  11.3
CGGTTGAT AGCAACCG A:G 23.7 ± 0.7 28.1 ± 0.7  6.2
CGGTTGAU-NA AGCAACCG A:G 27.3 ± 1.0 32.2 ± 0.7  7.6
aSequencesaregiven50-to3 0-terminus;Udenotes20-amino-20-deoxyuridineresidueandNAtheresidueofnalidixicacid.Nucleobasesatpositionswheremismatches
were introduced are given in boldface.
bAverage of four Tms ± SD at 1.5 mM strand concentration and NH4OAc concentration given as [salt].
cTm difference to duplex with fully complementary target at 1 M NH4OAc.
dThese values were determined independently from those in reference (27), and agree with the literature values within the error margins.
Nucleic Acids Research, 2005, Vol. 33, No. 15 4845respectively (27). The 11 C Tm increase per modiﬁcation is
more than that an additional base pair would provide, even if it
was a C:G base pair. Since (6)2 shows only 4 bp, one might
also compare the 53.1 C with the Tm of the core tetramer
duplex d(CGCG)2. For the latter, HyTher (52) predicts a Tm
of 2.2 Ca t4mM total strand concentration and 1 M mono-
valent salt, i.e. 50 C below that of the nalidixic acid-
containing duplex with its re-folded base pair, including a
putative single H-bond between A1 and U6. It is not particu-
larly probable that a small molecule like nalidixic acid has
many different binding modes available that involve extensive
favorable interactions. If it does bind to DNA in the active site
of gyrases (and no model assumes that it does not) and man-
ages to stall the gyrase, it will probably do so through strong
favorable interactions. Finally, the shape of (6)2 is globally not
too different from that of a standard DNA helix. Nature
evolved gyrases to act on dsDNA, and the active site must
have evolved to ﬁt that substrate. Given the size of dsDNA
as a substrate, it is unlikely that a complex with a radically
different shape would ﬁt into the active site.
One interesting question is how much the covalent link
affects the exact position of the quinolone relative to the
DNA. This question is difﬁcult to answer, as the covalent
link seems to be necessary to prevent the ‘blurring’ of
complexes that prevented the generation of high resolution
structures in earlier NMR-studies on non-conjugated
quinolone–DNA complexes (53). But, the covalent link also
has an other noteworthy effect. It prevents the free association
of quinolones into stacks of more than one drug molecule. The
formation of stacks of four quinolones has been proposed in
models of the biological mode of action of quinolones (54).
What our structures and the Tms of the duplexes show is that
there is no need for the formation of quinolone–quinolone
complexes for very strong interactions with DNA to occur.
To demonstrate that the current high resolution structure
may be a useful starting point for modeling possible ternary
complexes of gyrases, quinolones and DNA, we generated two
non-covalent quinolone–DNA complexes based on the struc-
ture of (6)2 (Figure 10). The coordinates for these complexes
are given in the Supplementary Material. The ﬁrst is a non-
covalent complex of nalidixic acid with the DNA duplex
(ACGCGT)2, the other is a complex between the same
DNA and nalidixic acid with a ﬂuoro-substituent at position
6, i.e. the position where second generation chinolone antibi-
otics are most frequently ﬂuorinated. Either structure was
generated by restrained MD in CNS (42), starting from the
unmodiﬁed DNA hexamer and the respective quinolone as
separate molecules. During the MD, which were performed
exactly as in the case of (6)2, the NMR-based constraints used
for generating the structure of (6)2 were applied, except for
those constraints involving atoms not found in the non-
covalently linked complex. The force ﬁeld applied during
these calculations ensures physically reasonable structures.
Inspection of Figure 10 shows that the structures obtained
are tightly folded with good shape complementarity between
DNA and quinolones. In either case, the interactions are favor-
able, with total energies calculated by CNS below  400 kcal/
mol. The non-covalent structures show features of the qualit-
ative model for quinolone–DNA complex in the active site of
gyrases proposed by Maxwell and co-workers (30,31) and
should provide a possible starting point for modeling ternary
complexes with the enzyme.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at NAR Online.
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